U.S. Life Sciences Stock News

Thinking about what to do with Coca-Cola stock? You are not alone. With its status as one of the most recognizable consumer brands in the world, Coca-Cola often finds itself at the crossroads of value and potential. Lately, the stock price has offered some signals that are worth a closer look. Over the last month, shares have inched up nearly 0.9%, and year to date, KO is up about 14.3%. While the last quarter saw a minor dip, this was against a fairly stable broader market mood and growing...

Rhythm Pharmaceuticals (RYTM) just received a significant decision from the FDA, as their supplemental New Drug Application for setmelanotide was not only accepted for filing but also granted Priority Review status. This indicates that the agency sees potential for the medication to address an urgent, unmet need for people dealing with acquired hypothalamic obesity. Investors familiar with Rhythm know setmelanotide already has approvals for rare genetic obesity disorders. This proposed...

DENTSPLY SIRONA Inc. announced its second quarter 2025 results in August, revealing sales of US$936 million and a net loss of US$45 million, with management reaffirming its full-year sales guidance of US$3.60 billion to US$3.70 billion amid continued industry headwinds. An interesting aspect is the board’s decision to maintain its dividend at US$0.16 per share, contrasting with ongoing revenue pressure and signaling a commitment to shareholder returns despite financial challenges. We’ll...

Thinking about investing in Vulcan Materials, or maybe deciding whether to hold on to your shares? You are in good company. Vulcan Materials has caught the attention of market watchers, especially after its stock price shrugged off some short-term dips and delivered an impressive 16.4% return over the past year. That is a performance hard to ignore, especially when you look at its nearly 143% total return over five years. Recent months have shown a blend of resilience and optimism, with the...

If you have your eye on Live Nation Entertainment stock, you are not alone. With concerts and live experiences roaring back, investors have seen the company’s share price climb an impressive 25% so far this year and over 67% over the past twelve months. That kind of run naturally raises the question: does LYV have more room to run, or is the market already pricing in all that potential? Digging a bit deeper, LYV’s journey has been anything but boring. In just the past three months, the stock...

NasdaqGS:JD 1 Year Share Price vs Fair Value Explore JD.com's Fair Values from the Community and select yours JD.com...

Thinking about what to do with Pony AI stock? You are not alone. As one of the more intriguing names in the autonomous vehicle sector, Pony AI has experienced its fair share of twists and turns recently. For traders and long-term investors alike, the past few months have brought some big price swings that demand a closer look. Let us start with the numbers. After a dip of nearly 28% over the past 90 days, Pony AI has rebounded with a 15.6% climb over the last month. That recent rally, coupled...

Earlier this month, Duke Energy announced it submitted the final license application to the Federal Energy Regulatory Commission for its Bad Creek Pumped Storage Hydroelectric Station in South Carolina, seeking to extend the plant’s operations for another 50 years and add 320 megawatts of carbon-free energy following recent upgrades. This major licensing step signals Duke Energy's continued investment in large-scale grid storage and emissions-free generation as it supports growing regional...

If you have been eyeing Northrop Grumman, you are in good company. The stock has been grabbing attention for its impressive run over the last few months. With a year-to-date return of about 27% and a 90-day gain of 25%, it is fair to ask if the market is finally catching up to Northrop's prospects, or if there is more room to grow, or perhaps risks to consider. Recent news has fueled the conversation around NOC. The company announced plans to quadruple its chip output by 2030, signaling...

Thinking about whether to hold, buy, or sell Oracle? You are in good company. Oracle’s stock has experienced considerable volatility, with short-term dips but significant growth over the past year. In just the last 90 days, shares are up almost 50%, and that one-year return is nearly 70%. Clearly, something notable is happening behind the scenes. What is driving these swings? For one, Oracle continues to secure major deals and draw investment headlines. Over the past month, news broke that...

Performance Food Group reported its fourth quarter and full-year 2025 results, delivering US$16.94 billion in quarterly sales and offering guidance for fiscal 2026 sales between US$67 billion and US$68 billion. Despite higher sales, the company posted a year-over-year decline in both quarterly and full-year net income, prompting management to highlight continued efficiency initiatives and disciplined capital allocation, including share buybacks and potential acquisitions. We'll explore how...

Several law firms recently announced class action lawsuits against Lockheed Martin, alleging that the company failed to disclose internal control weaknesses and overstated its ability to deliver on contract commitments, following the disclosure of significant pre-tax losses on classified programs in late 2024, early 2025, and July 2025. These lawsuits claim that Lockheed Martin made materially misleading statements, which has resulted in substantial attention from investors and triggered a...

On August 12, 2025, Sila Realty Trust, Inc. announced a US$250 million at-the-market follow-on equity offering and filed a comprehensive shelf registration for multiple types of securities, including common and preferred stock, depositary shares, warrants, purchase contracts, and units. This move expands Sila Realty Trust’s capital-raising flexibility while also raising important questions about potential dilution and capital deployment priorities for investors. We’ll examine how Sila’s...

Thinking about what to do next with Johnson Controls International stock? You are not alone. Investors have been watching JCI’s distinct price action over the past year and weighing up the company’s future, especially as expectations across the industrial sector keep shifting. After a rollercoaster 2023, the past twelve months have brought a substantial total return of about 53% for Johnson Controls’ shareholders. That impressive run comes in addition to a hefty 104% return over three years,...

General Mills (GIS) just slipped into headlines after another dip, as shares gave up roughly half a percent at the close. The move might seem modest, but it is enough to catch some investors’ attention, especially for those watching the food sector’s defensive names. Without a single event behind the slide, it does raise the question: are traders simply recalibrating expectations, or is something bigger brewing under the surface? If you pan out, the bigger story comes into focus. Over the...

Key Insights TROOPS' significant insider ownership suggests inherent interests in company's expansion A total of 3...

O’Reilly Automotive recently completed a buyback tranche, repurchasing 9,404,000 shares for US$857.19 million between April and August 2025, finalizing a very large buyback program that started in 2011. This substantial completion of the repurchase initiative signals management’s ongoing confidence in the company’s long-term performance and their commitment to returning capital to shareholders. With the buyback program now complete, we’ll consider how returning capital to shareholders could...

If you are trying to make sense of Insulet’s recent run, you are not alone. Whether you already hold shares or are weighing a new buy, it is tough to look away from a stock that has powered up nearly 30% year-to-date and delivered a whopping 79% total return over the past year. The buzz makes sense, with Insulet’s sales up by more than 14% and annual net income growth topping 23%. All of this comes with the shares closing recently at $333, just a modest 5.7% below the average analyst price...

If you held shares of Uranium Energy (UEC) over the past month, you probably noticed your portfolio got a boost. The stock climbed nearly 17% in that period. There has been no game-changing headline or sudden corporate announcement to spark this run, but that kind of momentum is enough to get any investor wondering if the market sees value others have missed, or if this is just another blip in a volatile sector. This move fits into a bigger picture of rising momentum for Uranium Energy,...

On August 12, 2025, Insmed Incorporated announced that the U.S. FDA approved BRINSUPRI (brensocatib), the first and only FDA-approved oral therapy for non-cystic fibrosis bronchiectasis in adults and children 12 years and older, with Maxor Specialty Pharmacy later selected as a limited distribution provider. This approval not only introduces a first-in-class treatment for an underserved patient population but also positions Insmed to potentially establish a new standard of care for...

If you have been following Cigna Group (CI) lately, you’ve probably noticed the stock’s share price drifting higher. The increase has been subtle, but just enough to catch the eye. There hasn’t been a single major announcement sparking this move; however, with a share price now sitting above $300 and a year-to-date gain over 10%, many investors are wondering whether the recent momentum is revealing something about sentiment or simply reflects the normal ebb and flow of a maturing company...

Something caught your eye with Northern Trust (NTRS) today? While there is no breaking development triggering an abrupt move, this recent bump in the share price might have some investors wondering if market optimism is building or simply reacting to shifting expectations. In moments like this, it pays to look under the hood and see if this near-term momentum matches up with the underlying business or if we are just seeing market noise. Over the past year, Northern Trust stock has recorded a...

W. R. Berkley (WRB) just unveiled Berkley Edge, a brand-new operation dedicated to serving small and mid-sized businesses with professional liability and casualty insurance, especially in cases that are tough to underwrite. This move, along with the appointment of industry veteran Jamie Secor to lead the venture, is a clear statement about where the company sees opportunity: in specialty insurance, targeting risks that many competitors pass by. For investors, this expansion is worth a closer...

If you are sitting on the fence about what to do with BWX Technologies stock right now, you are definitely not alone. With its impressive run over the last year, climbing more than 63%, BWXT has landed squarely on the radar for many investors searching for growth stories and stable plays alike. The stock’s gains are even more eye-catching when you zoom out, doubling over the last three and five years, and surging more than 51% in just the past three months. These outsized returns tell a story...